3/25
02:20 pm
tvgn
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
Low
Report
Tevogen Regains Compliance with Nasdaq Minimum Bid Price Requirement
3/21
01:31 am
tvgn
Medium
Report
3/18
01:00 pm
tvgn
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) [Yahoo! Finance]
Low
Report
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026) [Yahoo! Finance]
3/18
12:22 pm
tvgn
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
Medium
Report
Tevogen CIO and Head of Tevogen.AI Mittul Mehta to Speak at Microsoft Fabric Community Conference (FabCon 2026)
3/13
03:09 pm
tvgn
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization [Yahoo! Finance]
Low
Report
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization [Yahoo! Finance]
3/13
02:45 pm
tvgn
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
Medium
Report
Tevogen Reaffirms Capital Discipline as Lead Investor Maintains Holdings and Company Limits Share Utilization
3/13
12:30 pm
tvgn
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
High
Report
Tevogen.AI Reports Advancements in PredicTcell™ Beta, Demonstrates Improved Precision Metrics and Expands Proprietary AI Infrastructure
3/11
03:15 pm
tvgn
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
Low
Report
Tevogen CEO Dr. Ryan Saadi Reaffirms Clinical Commitment During International Long COVID Awareness Month; Highlights Synergies of New Leadership Team and Digital Care Platform
3/9
08:02 am
tvgn
Tevogen Names Leadership Team to Execute Diversified Growth Strategy [Yahoo! Finance]
High
Report
Tevogen Names Leadership Team to Execute Diversified Growth Strategy [Yahoo! Finance]
3/9
07:45 am
tvgn
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
High
Report
Tevogen Names Leadership Team to Execute Diversified Growth Strategy
3/6
04:18 pm
tvgn
Letter to Shareholders from CEO Dr. Ryan Saadi [Yahoo! Finance]
Medium
Report
Letter to Shareholders from CEO Dr. Ryan Saadi [Yahoo! Finance]
3/5
03:11 pm
tvgn
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical [Yahoo! Finance]
Low
Report
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical [Yahoo! Finance]
3/5
02:50 pm
tvgn
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
Low
Report
Tevogen Advances Generics Strategy, Signs Letter of Intent to Evaluate Potential Acquisition of Apozeal Pharmaceutical
3/4
10:00 am
tvgn
Tevogen Bio (TVGN) was downgraded by D. Boral Capital from "buy" to "hold".
Low
Report
Tevogen Bio (TVGN) was downgraded by D. Boral Capital from "buy" to "hold".
3/4
08:00 am
tvgn
Tevogen Announces Reverse Stock Split
Low
Report
Tevogen Announces Reverse Stock Split
3/3
03:55 pm
tvgn
Tevogen Bio (TVGN) had its price target lowered by D. Boral Capital from $5.00 to $2.00. They now have a "buy" rating on the stock.
Low
Report
Tevogen Bio (TVGN) had its price target lowered by D. Boral Capital from $5.00 to $2.00. They now have a "buy" rating on the stock.
2/27
02:20 pm
tvgn
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
Low
Report
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Contract Research Organization
2/26
04:22 pm
tvgn
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
High
Report
UPDATE - Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
2/26
09:20 am
tvgn
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
Low
Report
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of Sciometrix and its Digital Care Management Platform Clinicus
1/30
03:33 pm
tvgn
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders [Yahoo! Finance]
Medium
Report
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders [Yahoo! Finance]
1/30
03:00 pm
tvgn
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
Medium
Report
Tevogen Board to Evaluate Potential One-Time Special Cash Dividend to Shareholders
1/29
03:18 pm
tvgn
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue [Yahoo! Finance]
Low
Report
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue [Yahoo! Finance]
1/29
02:45 pm
tvgn
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
Low
Report
Tevogen to Align Long-Term Stock-Based Incentive Program With Company Milestones, Including Revenue
1/12
09:00 am
tvgn
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025
High
Report
Tevogen Demonstrates Platform Scalability and Multi-Indication T Cell Pipeline Expansion in 2025